Peptides DB
Research-centric peptide and protocol reference hub
Study 20 of 20GHRP-6 literatureJournal of pediatric endocrinology & metabolism : JPEM · ObservationalHigh-impact journal2003

A practical approach to the diagnosis of growth hormone (GH) deficiency in patients transitioning to adulthood using GH stimulation testing.

The choice of testing methods for diagnosing adult growth hormone deficiency significantly impacts outcomes, with some children diagnosed with idiopathic GHD retesting normally.

Read at Journal of pediatric endocrinology & metabolism : JPEMAdd to compare

Where it sits

this study against the rest of the ghrp-6 corpus
2
Preclinical
14
Observational · this one
0
Open-label
1
Randomised
3
Reviews

Summary and findings

The study evaluates the diagnosis of adult growth hormone deficiency (GHD) in children transitioning to adulthood after ceasing GH therapy. It discusses the variability in retesting results among children diagnosed with idiopathic GHD and the impact of different stimuli on GH responses. The findings highlight the importance of testing methods in diagnosing GHD.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Stimulated peak serum GH concentrations <5 ng/ml if measured by polyclonal radioimmunoassays.2003

Abstract

The authors’ words, as Journal of pediatric endocrinology & metabolism : JPEM supplied them

To establish the diagnosis of adult growth hormone deficiency (GHD), GH-deficient children transitioning to adulthood are evaluated by two separate stimuli 2 or more weeks after ceasing GH therapy. While 20-88% of children diagnosed with idiopathic GHD retest with normal values, those with proven genetic defects in GH production/secretion/bioactivity and patients with panhypopituitarism consistently test deficient. The US Food and Drug Administration (FDA) defines GHD in adults by stimulated peak serum GH concentrations <5 ng/ml if measured by polyclonal radioimmunoassays (RIA) or lower if measured by monoclonal assays. Some investigators define severe GHD by a peak GH concentration <3 ng/ml. Adult responses to arginine and glucagon testing are similar to the responses to insulin tolerance testing; clonidine, pyridostigmine, and galanin cause lesser peaks of GH. Growth hormone-releasing hormone (GHRH) combined with arginine, GH releasing peptide-6 (GHRP-6), or hexarelin leads to higher peak responses than GHRH alone. Thus the choice of testing methods impacts the diagnosis of GHD in transition patients.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the GHRP-6 corpus

CThe Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.International heart journal · 2017 · Not reported in abstract.AnimalBLDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255/miR-192-5p/ATG2A axis.Bioactive materials · 2026 · Not reported in abstract.HumanCLoss of EGFR activity in skeletal stem/progenitor cells is associated with impaired fracture healing in aged mice.Bioactive materials · 2026 · Not reported in abstract.AnimalCLong-term exploratory evaluation of an acellular biomimetic polyfascicular nerve guidance conduit for peripheral nerve repair in a rhesus macaque model.Bioactive materials · 2026 · n=3 · 94% reduction in PLCL molecular weight at 12 months.AnimalCAreca catechu L. procyanidins alleviate pulmonary fibrosis by suppressing the TGF-β/Smad/ERK cascade: Validation of a traditional herbal medicine.Journal of ethnopharmacology · 2026 · ANP significantly reduced collagen deposition (HYP), p-Smad3/4, and p-ERK levels.AnimalCIn vivo antimalarial activity and acute toxicity of organic and aqueous leaf, stem and root extracts of Ajuga integrifolia Buch.-Ham. ex D. Don.Journal of ethnopharmacology · 2026 · Organic stem extracts at 500 mg/kg/day suppressed parasite growth by 66.73%.Animal